Loading insider details...
Beta
Latest Form 4 (Sep 12, 2026): Sale of 14,754 AARD shares, $73.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 12, 2026 | Aardvark Therapeutics, Inc. (AARD) | Sale | 14,754 | $73.8K |
| Feb 12, 2026 | Aardvark Therapeutics, Inc. (AARD) | Grant/Award | 70,549 | n/a |
| Dec 13, 2025 | Aardvark Therapeutics, Inc. (AARD) | Purchase | 3,000 | $43.2K |
| Sep 10, 2025 | Aardvark Therapeutics, Inc. (AARD) | Purchase | 6,000 | $48.4K |
| Jun 13, 2025 | Aardvark Therapeutics, Inc. (AARD) | Grant/Award | 209,826 | n/a |
| Feb 19, 2025 | Aardvark Therapeutics, Inc. (AARD) | Conversion | 7,001 | n/a |